To assess the impact of apoA-I on MASLD development, we established a mouse model of MASLD using a high-fat, high-cholesterol, high-fructose diet (HFCFD) (Figure 1A and S1A,B). Here, APOA1 is linked to metabolic dysfunction-associated steatotic liver disease.